INTERNATIONAL PATENT: ARGENX BV, UMC UTRECHT HOLDING B.V. FILES APPLICATION FOR "METHODS OF TREATING OSTEOARTHRITIS AND OSTEOARTHRITIS PAIN WITH AN ANTI COMPLEMENT C2 ANTAGONISTIC ANTIBODY"

GENEVA, Nov. 24 -- ARGENX BV (Industriepark-Zwijnaarde 79052 Zwijnaarde (Ghent)), UMC UTRECHT HOLDING B.V. (Heidelberglaan 83584CS Utrecht) filed a patent application (PCT/EP2025/063575) for "METHODS OF TREATING OSTEOARTHRITIS AND OSTEOARTHRITIS PAIN WITH AN ANTI COMPLEMENT C2 ANTAGONISTIC ANTIBODY" on May 16, 2025. With publication no. WO/2025/238225, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EIJKELKAMP, Niels (c/o UMC Utrecht Holding B.V.3584CS Heidelberglaan 8), VAN DE WALLE, Inge (c/o argenx BVIndustriepark-Zwij...